Choice analysis in health valuation

At this Student Research Webinar (60 min), Maksat Jumamyradov (University of South Florida, Tampa, USA) will present his three recent papers on choice analysis in health valuation, describing biases in conditional and mixed logit estimates when preferences are heterogeneous. After his presentation (30 minutes), he will answer questions from David Mott (OHE, London, UK) and Yiting Luo (Centre for Health Economics…

Read More

EQ-5D-Y Singapore and TTO Distortion

Rachel Lee-Yin Tan (National University of Singapore) will present her research on the EQ-5D-Y as a preference-based HRQoL instrument for use in paediatrics in Singapore. Zhongyu Lang (Erasmus University) will present his findings employing episodic future thinking to reduce the distortion of time preference in time trade-off (TTO). After their brief presentations (15 minutes each), they will answer…

Read More

Assessing Population Health

This Core Knowledge Panel (90 min) starts with an introduction to the assessment of population health by Juanita Haagsma (Erasmus MC), who co-chairs the Populations and Health Systems Working Group. After this overview, Fatima Al Sayah (University of Alberta) will introduce the EuroQol – Data for Assessment of Population Health Needs and Instrument Evaluation (EQ-DAPHNIE)…

Read More

The Validity of the EQ-5D in Clinical Practice and among Indigenous People

Irene Salvi (University of St. Gallen) will present her research on minimal important differences (MID) of EQ-5D-3L index score improvements adjusted for different patient characteristics after hip and knee replacements. Lilla Roy (University of Alberta) will share what she has learned about how valid the EQ-5D-5L might be for Indigenous people living in urban Alberta,…

Read More

How the EuroQol Office can help you

This Core Knowledge Panel (90 min) starts with an introduction to the EuroQol Office by Bernhard Slaap (Executive Director, EuroQol Research Foundation, Rotterdam, the Netherlands). After this overview, James W. Shaw (Executive Director and Head, Patient-Reported Outcomes Assessment, WWHEOR at Bristol Myers Squibb) and Caitlyn T. Solem (Director, Pipeline Strategy, US Oncology Value Evidence and…

Read More

41st EuroQol Plenary 2024

At the EuroQol Plenary, members and co-workers of the EuroQol Group present papers on topics that include methodological/valuation aspects of EQ-5D; development of EQ-5D versions in different languages and the use of EQ-5D in health population surveys. Additionally, there are poster sessions that focus mainly on the different clinical areas where EQ-5D is being applied.

Read More

EQ-5D-5L in obstructive airway disease

EQ-5D-5L in obstructive airway disease

Ai Ping Chua (National University of Singapore) will present the appraisal of the EQ-5D-5L in the obstructive airway diseases using a longer recall period and frequency-based responses. After this brief presentation, the presenter will answer a few questions from Bernhard Michalowsky (German Center for Neurodegenerative Diseases [DZNE]) as well as attendees.

Read More

EQ-5D-Y Implementation and AHP for Bolt-ons

Implementation and AHP for Bolt ons

Renee Jones (University of Melbourne) seeks to qualitatively understand clinician, parent and child perspectives on using the EQ-5D-Y in routine clinical care for children and to co-design how the EQ-5D-Y could be used and implemented in outpatient clinics. Cheuk Wai Ng (Hong Kong University of Science and Technology) will present on his application of analytical…

Read More

EQ-5D-Y Brazil and Children’s perceptions of HRQoL

Caique de Melo do Espirito Santo (Universidade Cidade de São Paulo) will present his studies on the psychometric properties and values of EQ-5D-Y-3L and -5L in Brazil. Diana Khanna (Flinders University) will present on differences in perceptions of HRQoL between adults and children in Australia. After their brief presentations, they will answer questions from Nancy…

Read More